CAS 1345982-69-5

Linerixibat

CAS : 1345982-69-5

Linerixibat

Degré de pureté : ≥98%

Masse moléculaire : 546.68g/mol

Ref: 54-BUP05499

Linerixibat

CAS : 1345982-69-5

Linerixibat (GSK2330672) is a highly effective, nonabsorbable ASBT inhibitor. Linerixibat can lower glucose in an animal model of type 2 diabetes.

Formule : C₂₈H₃₈N₂O₇S

Degré de pureté : 98.5% - 99.98%

Couleur et forme : Solid

Masse moléculaire : 546.68

Ref: TM-T3978

Linerixibat

CAS : 1345982-69-5

Formule : C₂₈H₃₈N₂O₇S

Masse moléculaire : 546.68

Ref: 4Z-L-217001

Linerixibat

CAS : 1345982-69-5

Linerixibat is an investigational pharmaceutical compound classified as an ileal bile acid transporter (IBAT) inhibitor. It is derived from chemical synthesis and acts by selectively targeting the IBAT, also known as the apical sodium-dependent bile acid transporter (ASBT), located in the distal ileum of the small intestine. By inhibiting this transporter, Linerixibat reduces the reabsorption of bile acids from the intestinal lumen, which leads to increased fecal bile acid excretion and reduced systemic levels of bile acids.

Formule : C₂₈H₃₈N₂O₇S

Degré de pureté : Min. 95%

Masse moléculaire : 546.68 g/mol

Ref: 3D-VDC98269